![(All-Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]-4,7,10,13,16,19-docosahexaenamide](https://static.cymitquimica.com/products/3D/img/EFA02487.png "Cliccare per ingrandire")
(All-Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]-4,7,10,13,16,19-docosahexaenamide
CAS: 129024-87-9
Rif. 3D-EFA02487
| 1mg | Fuori produzione | ||
| 5mg | Fuori produzione | ||
| 10mg | Fuori produzione | ||
| 25mg | Fuori produzione | ||
| 50mg | Fuori produzione |
Informazioni sul prodotto
Nome:
(All-Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]-4,7,10,13,16,19-docosahexaenamide
Sinonimi:
- 4,7,10,13,16,19-docosahexaenamide, N-[2-(3,4-dihydroxyphenyl)ethyl]-, (4Z,7Z,10Z,13Z,16Z,19Z)-
Descrizione:
(All-Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]-4,7,10,13,16,19-docosahexaenamide is a phenoxy compound that has been shown to have pharmacological effects in both animals and humans. It is an amide with a polyunsaturated fatty acid chain. This drug inhibits the pathogenic mechanism of glp-1 analogues and analogues on primary cells such as neurons and pancreatic beta cells. (All-Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]-4,7,10,13,16,19-docosahexaenamide has also been shown to be neuroprotective in animal models. The mechanism of this protective effect is still not clear but it appears to be related to the ability of this drug to inhibit the release of endogenous substances such as dopamine or fatty acids.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
463.7 g/mol
Formula:
C30H41NO3
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
